129 related articles for article (PubMed ID: 9011420)
1. [Splenectomy in osteomyelofibrosis. Indications and outcome].
Böhner H; Rötzscher VM; Tirier C; Heit W; Greiner J
Chirurg; 1996 Oct; 67(10):1016-9. PubMed ID: 9011420
[TBL] [Abstract][Full Text] [Related]
2. Massive splenomegaly and extramedullary hematopoiesis in chronic idiopathic myelofibrosis.
Montague N; De La Ossa M
Blood; 2010 Oct; 116(14):2410. PubMed ID: 20949696
[No Abstract] [Full Text] [Related]
3. Idiopathic myelofibrosis without dacryocytes.
Chen GL; Liu E; Naidoo K; Popat U; Coetzer TL; Prchal JT
Haematologica; 2006 Jun; 91(6 Suppl):ECR29. PubMed ID: 16785132
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
5. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
Lafaye F; Rain JD; Clot P; Najean Y
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
[TBL] [Abstract][Full Text] [Related]
6. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
7. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Ward HP; Block MH
Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
[No Abstract] [Full Text] [Related]
8. Myelofibrosis and rapid thrombocytolysis. A case report.
Kutti J; Bergström AL; Ridell B
Acta Med Scand; 1977; 201(3):249-55. PubMed ID: 848365
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
[TBL] [Abstract][Full Text] [Related]
10. [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen].
Dechavanne M; Viala JJ; Barbier Y; Revol L
Sem Hop; 1972 Apr; 48(17):1187-92. PubMed ID: 4342370
[No Abstract] [Full Text] [Related]
11. [Pylethrombosis following splenectomy (author's transl)].
Aufschnaiter M; Salzer GM
MMW Munch Med Wochenschr; 1981 Oct; 123(40):1503-5. PubMed ID: 6795460
[TBL] [Abstract][Full Text] [Related]
12. Immunohistopathological Analysis of Extramedullary Hematopoiesis and Angiogenesis of Spleen in a Case of Primary Myelofibrosis with Huge Splenomegaly.
Kawano N; Saito N; Yoshida S; Kitanaka A; Shide K; Marutsuka K; Ohshima K; Shimoda K
Tohoku J Exp Med; 2022 Feb; 256(2):119-125. PubMed ID: 35173090
[TBL] [Abstract][Full Text] [Related]
13. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
Petroianu A
Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy for agnogenic myeloid metaplasia.
Gomes MR; Silverstein MN; Remine WH
Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
[No Abstract] [Full Text] [Related]
15. Splenectomy? No, thank you!
Huić D; Labar B; Huić M; Radman I; Dodig D; Mrsić M
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1677. PubMed ID: 15241628
[No Abstract] [Full Text] [Related]
16. [Role of splenectomy in the treatment of myelofibrosis].
Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
[TBL] [Abstract][Full Text] [Related]
17. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
[TBL] [Abstract][Full Text] [Related]
18. Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis--an entity different from adults.
DeLario MR; Sheehan AM; Ataya R; Bertuch AA; Vega C; Webb CR; Lopez-Terrada D; Venkateswaran L
Am J Hematol; 2012 May; 87(5):461-4. PubMed ID: 22389089
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
20. Indications for and results of splenectomy in different hematological disorders.
Böhner H; Tirier C; Rötzscher VM; Heit W
Langenbecks Arch Chir; 1997; 382(2):79-82. PubMed ID: 9128872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
